Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

The effects of oral vitamin D supplementation on linear growth and non‐communicable diseases among infants and children younger than five years of age

This is not the most recent version

Information

DOI:
https://doi.org/10.1002/14651858.CD012875Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 16 November 2017see what's new
Type:
  1. Intervention
Stage:
  1. Protocol
Cochrane Editorial Group:
  1. Cochrane Developmental, Psychosocial and Learning Problems Group

Copyright:
  1. Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Elaine A Yu

    Division of Nutritional Sciences, Cornell University, Ithaca, USA

  • Samantha L Hueya

    Division of Nutritional Sciences, Cornell University, Ithaca, USA

    Shares first authorship

  • Juan Pablo Peña‐Rosas

    Evidence and Programme Guidance, Department of Nutrition for Health and Development, World Health Organization, Geneva, Switzerland

  • Saurabh Mehta

    Correspondence to: Division of Nutritional Sciences, Cornell University, Ithaca, USA

    [email protected]

Contributions of authors

Elaine Yu and Samantha Huey drafted the protocol.
Juan Peña‐Rosas and Saurabh Mehta (SM) revised and critically reviewed the protocol.
All review authors contributed to writing of the protocol, as well as to extensive feedback and revisions.
SM is the guarantor for the review.

Sources of support

Internal sources

  • Division of Nutritional Sciences, Cornell University, USA.

    SM is faculty, and SH and EY are doctoral candidates of the Division of Nutritional Sciences at Cornell University.

  • Evidence and Programme Guidance, Department of Nutrition for Health and Development, World Health Organization (WHO), Switzerland.

    JP‐R is a full‐time member of staff of the Department of Nutrition for Health and Development at the WHO.

External sources

  • Bill & Melinda Gates Foundation, USA.

    WHO gratefully acknowledges financial support from the Bill & Melinda Gates Foundation.

  • Nutrition International (formerly Micronutrient Initiative), Canada.

    WHO acknowledges the financial contribution of Nutrition International for commissioning of systematic reviews of evidence on the effects of nutrition interventions.

  • Global Affairs Canada, Canada.

    WHO gratefully acknowledges the financial support provided by Global Affairs Canada to the Department of Nutrition for Health and Development for this work.

Declarations of interest

Elaine Yu ‐ none known.

Samantha Huey ‐ none known.

Juan Peña‐Rosas declares that the Evidence and Programme Guidance Unit, Department of Nutrition for Health and Development, at the World Health Organization (WHO), receives financial resources from several external sources for biennium 2016 to 2017 from the Bill & Melinda Gates Foundation (2016 to 2019); US Centers for Disease Control and Prevention (CDC; 2014 to 2019); Nutrition International (formerly Micronutrient Initiative; 2014 to 2017), and the US Agency for International Development (USAID; 2014 to 2018). Donors do not fund specific guidelines and do not participate in any decisions related to the guideline development process, including composition of policy questions, membership of guideline groups, conduct and interpretation of systematic reviews, or formulation of recommendations.

Saurabh Mehta (SM) is an unpaid board member of a diagnostic start‐up company that is focused on developing assays for low‐cost and point‐of‐care measurement of certain nutrients from a drop of blood, using results from his research as a faculty member at Cornell University. SM is also the principal investigator on competitive grants from the HarvestPlus/International Food Policy Research Institute to conduct efficacy trials for bio‐fortified crops among children in India, for which one of the outcomes consists of child growth. SM received partial financial support for this work from the WHO.

Disclaimer: Juan Peña‐Rosas is a full‐time staff member at the Evidence and Programme Guidance Unit, Department of Nutrition for Health and Development, at the WHO. The review authors alone are responsible for the views expressed in this publication, which do not necessarily represent the official position, decisions, policy, or views of the WHO.

Acknowledgements

We gratefully acknowledge the Cochrane Developmental, Psychosocial and Learning Problems Review Group and the following individuals for their contributions: CDPLPG editors, external referees, statistician, and Ms Sarah Young (for her expertise and assistance in developing the initial search strategy). This protocol was developed during the WHO/Cochrane/Cornell University Summer Institute for Systematic Reviews in Nutrition for Global Policy Making, hosted at the Division of Nutritional Sciences, Cornell University, Ithaca, New York, USA, in 2015 (27 July to 7 August).

Version history

Published

Title

Stage

Authors

Version

2020 Dec 11

Effects of oral vitamin D supplementation on linear growth and other health outcomes among children under five years of age

Review

Samantha L Huey, Nina Acharya, Ashley Silver, Risha Sheni, Elaine A Yu, Juan Pablo Peña-Rosas, Saurabh Mehta

https://doi.org/10.1002/14651858.CD012875.pub2

2017 Nov 16

The effects of oral vitamin D supplementation on linear growth and non‐communicable diseases among infants and children younger than five years of age

Protocol

Elaine A Yu, Samantha L Huey, Juan Pablo Peña‐Rosas, Saurabh Mehta

https://doi.org/10.1002/14651858.CD012875

Keywords

MeSH

PICOs

Population
Intervention
Comparison
Outcome

The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.

See more on using PICO in the Cochrane Handbook.

Table 1. Intervention and comparator groups

Comparison

Intervention group

Comparator group

1. Oral vitamin D (cholecalciferol D3, ergocalciferol D2, calcitriol) supplementationa

1a. No intervention

1b. Placebo

2. Other micronutrientsb, including oral vitamin D (cholecalciferol D3, ergocalciferol D2, calcitriol) supplementationa

2. Other micronutrientsb not including vitamin D

aAny form, including capsules, soft gels, liquids, or powders.
bComparisons will include intervention and comparator groups with the same combination of various micronutrients, to isolate the effect of vitamin D.

Figures and Tables -
Table 1. Intervention and comparator groups